logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

In CRC liver metastases, cetuximab is linked to worse outcomes

Editorial says results imply potential detriment from neoadjuvant or perioperative EGFR antibodies.